Skip to main content

Adjournment debate on Thursday, 8 May 2008, in the House of Commons, led by Kevin Barron. The answering member was Baroness Primarolo.


National Institute for Health and Clinical Excellence

Westminster hall debate on a motion for the adjournment on the National Institute for Health and Clinical Excellence.[Relevant documents: Health Select Committee first report of session 2007-08, HC 27, and the Government's response, Cm 7331.)


Secondary information

Type
Parliamentary proceeding
Reference
475 c311-48WH 
Session
2007-08
Department
Department of Health
Chamber / Committee
Westminster Hall
Related items
Proceeding contributions
Baroness Primarolo | 475 c343-4WH (Link to this contribution) There are two steps in the discussion and several processes are involved. The first is to assess wha...
Sandra Gidley | 475 c343WH (Link to this contribution) I welcome the Minister's sentiment, but one of the problems in Hampshire, which the hon. Member for ...
Show all contributions (53)
Maria Miller | 475 c344WH (Link to this contribution) I was taken aback to be told that the rethink of the IVF policy in Hampshire was going to be conduct...
Baroness Primarolo | 475 c344-5WH (Link to this contribution) The hon. Lady is, I believe, referring to the collection of information and to ensuring that PCTs te...
Kevin Barron | 475 c345-8WH (Link to this contribution) I shall be brief. I congratulate the Minister on speaking for 35 minutes and not mentioning the R-wo...
Kevin Barron | 475 c311-7WH (Link to this contribution) To preface the debate, I thank the secretariat of the Select Committee on Health, whose seven member...
Baroness Primarolo | 475 c317WH (Link to this contribution) I am sorry to interrupt my hon. Friend in mid flow, but I think that it would be helpful if I tell h...
Kevin Barron | 475 c317WH (Link to this contribution) I am grateful to the Minister for that. I know that if someone is given a strong letter that says th...
Maria Miller | 475 c327-8WH (Link to this contribution) The Minister has raised an important point. Presumably, what she as a Minister in the Department of ...
Maria Miller | 475 c325-6WH (Link to this contribution) It is with a little caution that I rise to speak after the hon. Members for Dartford (Dr. Stoate) an...
Ian Gibson | 475 c326WH (Link to this contribution) First, does the hon. Lady think that fastness is not always associated with accuracy of information,...
Maria Miller | 475 c326WH (Link to this contribution) I thank the hon. Gentleman for raising those points. I will discuss the length of time that should b...
Baroness Primarolo | 475 c326-7WH (Link to this contribution) The hon. Lady is touching on an important wider point for the health service, and perhaps she will s...
Ian Gibson | 475 c322WH (Link to this contribution) Would my hon. Friend include orphan drugs and ultra-orphan drugs in the mystique that he mentions, w...
Howard Stoate | 475 c322-4WH (Link to this contribution) I pay tribute to my hon. Friend, who does a huge amount of work for cancer patients and who has quit...
Sandra Gidley | 475 c324WH (Link to this contribution) We all like to get hung up on the question of thresholds, but surely the hon. Gentleman saw the evid...
Howard Stoate | 475 c324-5WH (Link to this contribution) I accept the hon. Lady's point, which underlines the great difficulty that we had in making some of ...
Howard Stoate | 475 c322WH (Link to this contribution) My hon. Friend makes the important point that we are moving in the right direction, but we have a lo...
Howard Stoate | 475 c321WH (Link to this contribution) I shall start by paraphrasing Kryten from the TV series ““Red Dwarf””. There are two problems facing...
David Drew | 475 c322WH (Link to this contribution) The Committee's Chairman referred to this earlier, but I have taken part in two events organised by ...
Richard Taylor | 475 c320-1WH (Link to this contribution) Oh! I have no information about how much those people get paid. No doubt some of guests in the Publi...
Ian Gibson | 475 c320WH (Link to this contribution) Why are there so few in Britain? Is it just not an appetising job?
Sandra Gidley | 475 c319WH (Link to this contribution) I am slightly confused by the hon. Gentleman saying that we do not want clinical freedom. I am sure ...
Richard Taylor | 475 c319-20WH (Link to this contribution) I am grateful for that helpful comment. I do not want to be misconstrued. I am talking about when it...
Ian Gibson | 475 c318-9WH (Link to this contribution) The hon. Gentleman talks about the need to get evidence earlier. Is that because it comes from the l...
Richard Taylor | 475 c319WH (Link to this contribution) That is one of the huge difficulties with drugs. Some of their effects—good and bad—are not discover...
Richard Taylor | 475 c318WH (Link to this contribution) It is a great privilege to follow our Chairman, who is allowing us to get out some quite strong cond...
Howard Stoate | 475 c318WH (Link to this contribution) The hon. Gentleman will appreciate that there is a great difference between time-honoured and eviden...
Richard Taylor | 475 c318WH (Link to this contribution) I thank my friend and medical colleague for that. I absolutely accept that, but things should not be...
Maria Miller | 475 c329WH (Link to this contribution) I thank the Minister for that. I am sure that what she has said is right, but when UK pharmaceutical...
Baroness Primarolo | 475 c329WH (Link to this contribution) I was at the annual dinner of the Association of the British Pharmaceutical Industry only last week....
Kevin Barron | 475 c332WH (Link to this contribution) When we took evidence from the would-be chair of the CQC in this morning's public session, we heard ...
Sandra Gidley | 475 c329-32WH (Link to this contribution) It is fair to point out in my opening remarks that the Committee has looked at the National Institut...
Sandra Gidley | 475 c332WH (Link to this contribution) Yes, but the matter is not being dealt with at the moment. The CQC will have enough problems trying ...
Mark Simmonds | 475 c332-4WH (Link to this contribution) First, may I say what a pleasure it is to have you in the Chair, Mr. Gale? I thank hon. Members, the...
Sandra Gidley | 475 c334WH (Link to this contribution) I agree wholeheartedly with the hon. Gentleman, but does he agree that one aspect of the inconsisten...
Mark Simmonds | 475 c334-7WH (Link to this contribution) I agree with the first part of the hon. Lady's intervention that this is an extremely important matt...
Sandra Gidley | 475 c337WH (Link to this contribution) I apologise to the hon. Gentleman for giving the impression that the appraisal committee was dominat...
Baroness Primarolo | 475 c339WH (Link to this contribution) If the hon. Lady will let me reassure her on one further point, I will happily give way. The basis f...
Baroness Primarolo | 475 c338-9WH (Link to this contribution) This has been an interesting and thoughtful debate, and I congratulate my right hon. Friend the Memb...
Baroness Primarolo | 475 c339WH (Link to this contribution) I agree that a constructive, productive working relationship with the pharmaceutical industry is vit...
Maria Miller | 475 c339WH (Link to this contribution) I completely endorse the Minister's remarks about value for money. Does she share my concern that th...
Mark Simmonds | 475 c337-8WH (Link to this contribution) I am grateful to the hon. Lady for clarifying that. The final point I shall make is about the implem...
Baroness Primarolo | 475 c340WH (Link to this contribution) I will give way to the hon. Lady and come back to the hon. Gentleman.
Baroness Primarolo | 475 c340WH (Link to this contribution) I do not agree with the one-sided view that the hon. Gentleman is giving with regard to the negotiat...
Mark Simmonds | 475 c340WH (Link to this contribution) I am grateful to the Minister for giving way. I just want to clarify a point that she has raised. Of...
Baroness Primarolo | 475 c340-3WH (Link to this contribution) Thank you, Mr. Gale. The Select Committee has raised these issues with me, and some of its recommend...
Speaker | 475 c340WH (Link to this contribution) Order. I have allowed the debate to continue because the future of the PPRS is clearly an important ...
Baroness Primarolo | 475 c340WH (Link to this contribution) On the first point, the agreement was between the Government and the industry. The points with regar...
Sandra Gidley | 475 c340WH (Link to this contribution) I have two quick questions. First, with the PPRS, am I correct in thinking that either side can ask ...
Subjects
Costs Health services Drugs NHS Medical treatments National Institute for Health and Care Excellence Research
Link
View this Parliamentary proceeding on www.publications.parliament.uk